{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T15:12:27Z","timestamp":1724685147930},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Municipal Education Commission","award":["KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037"],"award-info":[{"award-number":["KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037","KZ202010025037"]}]},{"name":"Beijing Hospitals Authority Youth Programme","award":["QML20211701","QML20211701","QML20211701","QML20211701","QML20211701","QML20211701","QML20211701"],"award-info":[{"award-number":["QML20211701","QML20211701","QML20211701","QML20211701","QML20211701","QML20211701","QML20211701"]}]},{"name":"Sino-German Mobility Programme","award":["M-0200","M-0200","M-0200","M-0200","M-0200","M-0200","M-0200"],"award-info":[{"award-number":["M-0200","M-0200","M-0200","M-0200","M-0200","M-0200","M-0200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00210-023-02428-2","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:30:32Z","timestamp":1678102232000},"page":"1847-1856","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid"],"prefix":"10.1007","volume":"396","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuheng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liujia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"issue":"6","key":"2428_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2428_CR2","doi-asserted-by":"publisher","first-page":"e2512","DOI":"10.1038\/cddis.2016.407","volume":"7","author":"R Chen","year":"2016","unstructured":"Chen R, Wang H, Liang B, Liu G, Tang M, Jia R, Fan X, Jing W, Zhou X, Wang H, Yang Y, Wei H, Li B, Zhao J (2016) Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation. Cell Death Dis 7(12):e2512","journal-title":"Cell Death Dis"},{"issue":"9","key":"2428_CR3","first-page":"2993","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N, Zhao Y (2020) Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res 10(9):2993\u20133036","journal-title":"Am J Cancer Res"},{"issue":"15","key":"2428_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.cub.2010.06.024","volume":"20","author":"W Cong","year":"2010","unstructured":"Cong W, Hirose T, Harita Y, Yamashita A, Mizuno K, Hirano H, Ohno S (2010) ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol 20(15):1408\u20131414","journal-title":"Curr Biol"},{"issue":"2","key":"2428_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","volume":"13","author":"T Couri","year":"2019","unstructured":"Couri T, Pillai A (2019) Goals and targets for personalized therapy for HCC. Hepatol Int 13(2):125\u2013137","journal-title":"Hepatol Int"},{"issue":"7","key":"2428_CR6","first-page":"8023","volume":"10","author":"W Huang","year":"2017","unstructured":"Huang W, Li X, Cai L (2017) Effects of ASPP2 on proliferation and apoptosis of malignant spinal tumor cells. Int J Clin Exp Pathol 10(7):8023\u20138030","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2428_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00418-020-01876-8","volume":"154","author":"T Konno","year":"2020","unstructured":"Konno T, Kohno T, Okada T, Shimada H, Satohisa S, Kikuchi S, Saito T, Kojima T (2020) ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer. Histochem Cell Biol 154(2):197\u2013213","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"2428_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156(2):477-491.e1","journal-title":"Gastroenterology"},{"key":"2428_CR9","doi-asserted-by":"publisher","first-page":"108898","DOI":"10.1016\/j.cbi.2019.108898","volume":"315","author":"K Kumar","year":"2020","unstructured":"Kumar K, Mishra J, Singh RP (2020) Usnic acid induces apoptosis in human gastric cancer cells through ROS generation and DNA damage and causes up-regulation of DNA-PKcs and \u03b3-H2A.X phosphorylation. Chem Biol Interact 315:108898","journal-title":"Chem Biol Interact"},{"issue":"11","key":"2428_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41419-019-2054-7","volume":"10","author":"B Liang","year":"2019","unstructured":"Liang B, Chen R, Song S, Wang H, Sun G, Yang H, Jing W, Zhou X, Fu Z, Huang G, Zhao J (2019) ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma. Cell Death Dis 10(11):830","journal-title":"Cell Death Dis"},{"issue":"1","key":"2428_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10620-017-4816-3","volume":"63","author":"M Lin","year":"2018","unstructured":"Lin M, Chang Y, Xie F, Shi Y, Pang L, Chen D (2018) ASPP2 inhibits the profibrotic effects of transforming growth factor-\u03b21 in hepatic stellate cells by reducing autophagy. Dig Dis Sci 63(1):146\u2013154","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2428_CR12","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1080\/21691401.2019.1664561","volume":"47","author":"L Liu","year":"2019","unstructured":"Liu L, Wang L, Li X, Tian P, Xu H, Li Z, Liu E (2019) Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2\/p38 signaling pathway in vitro and in vivo. Artif Cells Nanomed Biotechnol 47(1):3729\u20133736","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"2428_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","volume":"72","author":"JM Llovet","year":"2020","unstructured":"Llovet JM, Lencioni R (2020) mRECIST for HCC: performance and novel refinements. J Hepatol 72(2):288\u2013306","journal-title":"J Hepatol"},{"key":"2428_CR14","doi-asserted-by":"crossref","unstructured":"Lurje I, Czigany Z, Bednarsch J, Roderburg C, Isfort P, Neumann UP, Lurje G (2019) Treatment strategies for hepatocellular carcinoma - a multidisciplinary approach. Int J Mol Sci 20(6)","DOI":"10.3390\/ijms20061465"},{"issue":"6","key":"2428_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/13543776.2018.1472239","volume":"28","author":"OA Luzina","year":"2018","unstructured":"Luzina OA, Salakhutdinov NF (2018) Usnic acid and its derivatives for pharmaceutical use: a patent review (2000\u20132017). Expert Opin Ther Pat 28(6):477\u2013491","journal-title":"Expert Opin Ther Pat"},{"key":"2428_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","volume":"72","author":"JL Raoul","year":"2019","unstructured":"Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T (2019) Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev 72:28\u201336","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2428_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jcmm.12435","volume":"19","author":"Y Shi","year":"2015","unstructured":"Shi Y, Han Y, Xie F, Wang A, Feng X, Li N, Guo H, Chen D (2015) ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy. J Cell Mol Med 19(3):535\u2013543","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2428_CR18","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","volume":"13","author":"AG Singal","year":"2015","unstructured":"Singal AG, El-Serag HB (2015) Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol 13(12):2140\u20132151","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2428_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-015-0447-5","volume":"14","author":"B Song","year":"2015","unstructured":"Song B, Bian Q, Zhang YJ, Shao CH, Li G, Liu AA, Jing W, Liu R, Zhou YQ, Jin G, Hu XG (2015) Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation. Mol Cancer 14:177","journal-title":"Mol Cancer"},{"issue":"11","key":"2428_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41419-018-1145-1","volume":"9","author":"L Tian","year":"2018","unstructured":"Tian L, Deng Z, Xu L, Yang T, Yao W, Ji L, Lu Y, Zhang J, Liu Y, Wang J (2018) Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-\u03b9\/GLI1 pathway. Cell Death Dis 9(11):1115","journal-title":"Cell Death Dis"},{"issue":"44","key":"2428_CR21","doi-asserted-by":"publisher","first-page":"17969","DOI":"10.1073\/pnas.1309362110","volume":"110","author":"L Tordella","year":"2013","unstructured":"Tordella L, Koch S, Salter V, Pagotto A, Doondeea JB, Feller SM, Ratnayaka I, Zhong S, Goldin RD, Lozano G, McKeon FD, Tavassoli M, Fritzsche F, Huber GF, R\u00f6ssle M, Moch H, Lu X (2013) ASPP2 suppresses squamous cell carcinoma via RelA\/p65-mediated repression of p63. Proc Natl Acad Sci U S A 110(44):17969\u201317974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2428_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41417-021-00300-0","volume":"29","author":"S Wang","year":"2022","unstructured":"Wang S, Kou B, Chai M, Gao Y, Lin X, Yin L, Chen D, Liu X (2022) Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-\u03baB pathway in mice. Cancer Gene Ther 29(2):202\u2013214","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"2428_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2174\/1389201021666201002155955","volume":"22","author":"W Wu","year":"2021","unstructured":"Wu W, Gou H, Dong J, Yang X, Zhao Y, Peng H, Chen D, Geng R, Chen L, Liu J (2021) Usnic acid inhibits proliferation and migration through ATM mediated DNA damage response in RKO colorectal cancer cell. Curr Pharm Biotechnol 22(8):1129\u20131138","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"2428_CR24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbrc.2018.11.181","volume":"508","author":"T Yang","year":"2019","unstructured":"Yang T, Gao Y, Liu D, Wang Y, Wu J, Liu X, Shi Y, Chen D (2019) ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma. Biochem Biophys Res Commun 508(3):769\u2013774","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2428_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/jphp.13097","volume":"71","author":"B Yurdacan","year":"2019","unstructured":"Yurdacan B, Egeli U, GuneyEskiler G, Eryilmaz IE, Cecener G, Tunca B (2019) Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. J Pharm Pharmacol 71(7):1119\u20131132","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"2428_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/hep.23247","volume":"51","author":"J Zhao","year":"2010","unstructured":"Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y (2010) Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 51(1):142\u2013153","journal-title":"Hepatology"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02428-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T08:05:33Z","timestamp":1689149133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02428-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02428-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"30 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No clinical sources of human and\/ or animal studies were involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}